Overview

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the safety and effectiveness of ONTAK in previously treated patients with NHL.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Denileukin diftitox